Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fibrinolysis in cornea and conjunctiva: Evidence of two types of activators

  • 34 Accesses

  • 15 Citations

Abstract

The nature of corneal and conjunctival plasminogen activators (PAs) from human and rabbit eyes was examined in tissue culture. The fibrinolytic activity of culture fluid from human corneas was low, roughly one-eighth of that of rabbits. The main activity was found to be of the urokinase (UK) type, as demonstrated by crossed immunoelectrophoresis against alpha2-antiplasmin after incubation with mixed plasma. The fibrinolytic activity of culture fluid from human conjunctival tissue was higher and a mixed secretion of tissue type (tPA) and UK activator was demonstrated. These activators were separated by affinity chromatography against Sepharose-immobilized antibodies against tPA. Fibrinolytic activity in tears was quenched by antibodies against tPA but not by the use of anti-UK antibodies. Thus, in man, tear fibrinolytic activity may depend primarily on a release of PAs from conjunctival tissue.

This is a preview of subscription content, log in to check access.

References

  1. Åstedt B (1978) Immunological detection of tumour plasminogen activator in vitro and in vivo. In: Ruddon RW (ed) Biological markers of neoplasia: basic and applied aspects. Elsevier North Holland, New York, Oxford, Shannon, pp 481–489

  2. Åstedt B, Holmberg L (1976) Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture. Nature 261:595–597

  3. Berman M, Winthrop S, Ausprunk D, Rose J, Langer R, Gage J (1982) Plasminogen activator (urokinase) causes vascularisation of the cornea. Invest Ophtalmol Vis Sci 22:191–199

  4. Fraki JE, Lazarus GS, Gilgor RS, Marchase P, Singer KH (1983) Correlation of epidermal plasminogen activator with disease activity in psoriasis Br J Dermatatol 108:39–44

  5. Hashimoto K, Shafran KM, Webber PS, Lazarus GS, Singer KH (1983) Anti-cell surface pemphigus auto-antibody stimulates plasminogen activator activity in human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation. J Exp Med 157:259–272

  6. Holmberg L, Kristoffersson A-C, Lecander I, Wallen P, Astedt B (1982) Immunoradiometric quantification of tissue plasminogen activator secreted by fetal organs. Comparison with urokinase. Scand J Clin Lab Invest 42:347–354

  7. Lantz E, Andersson A (1982) Release of fibrinolytic activators from the cornea and conjunctiva. Graefe's Arch Clin Exp Ophthalmol 219:263–267

  8. Naito S, Taneka K, Kanamori T, Hisano S, Momose S (1982) Establishment of human pelvic cancer cell line producing thromboplastin and plasminogen activator. Urol Res 10:19–25

  9. Nilson IM, Olow B (1962) Fibrinolysis induced by streptokinase in man. Acta Chir Scand 123:247–266

  10. Nilson IM, Pandolfi M (1970) Fibrinolytic response of the vascular wall. Thromb Haemost [Suppl] 40:231–242

  11. Pandolfi M (1979) Hemorrhages and fibrinous exsudates in the anterior segment. In: Pandolfi M (ed) Hemorrhages in ophthalmology. A hemostatic approach. Thieme, Stuttgart, p 34

  12. Pandolfi M, Astrup T (1967) A histochemical study of fibrinolytic activity. Cornea, conjunctiva and lacrimal gland. Arch Ophthalmol 77:258–264

  13. Pandolfi M, Lantz E (1979) Partial purification and characterization of keratokinase, the fibrinolytic activator of the cornea. Exp Eye Res 29:563–571

  14. Pandolfi M, Åstedt B, Dyster-Aas K (1972) Release of fibrinolytic activators from human cornea. Acta Ophthalmol 50:199–205

  15. Radcliffe R, Heinze T (1981) Stimulation of tissue plasminogen activator by denatured proteins and fibrin clots: a possible additional role for plasminogen activator? Arch Biochem Biophys 211: 750–761

  16. Rijken DC, Collen D (1981) Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 256:7035–7041

  17. Thorsen S (1977) Human urokinase and porcine tissue plasminogen activator. Dan Med Bull 24: 189–206

  18. Vassalli J-D, Hamilton J, Reich E (1976) Macrophage plasminogen activator: Modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors and cyclic nucleotides. Cell 8:271–281

  19. Waring GO, Bourne WM, Edelhauser HF, Kenyon KR (1982) The corneal endothelium. Normal and pathologic structure and function. Ophthalmology 89:531–590

  20. Weeke B (1973) Crossed immunoelectrophoresis. In: Axelsen NH, Krøll J, Weeke B (eds) A manual of quantitative immunoelectrophoresis. Methods and applications. Scand J Immunol [Suppl] 2:47–56

  21. Yanoff M, Fine B (1975) In: Ocular pathology. Harper & Row, New York, p 8

Download references

Author information

Correspondence to Esbjörn Lantz.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lantz, E., Pandolfi, M. Fibrinolysis in cornea and conjunctiva: Evidence of two types of activators. Graefe's Arch Clin Exp Ophthalmol 224, 393–396 (1986). https://doi.org/10.1007/BF02173351

Download citation

Keywords

  • Public Health
  • Chromatography
  • Tissue Culture
  • Plasminogen
  • Plasminogen Activator